Trial Profile
Weekly and Every 3 Week Administration of Paclitaxel Liposome Injection in Metastatic Breast Cancer
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- Sponsors Nanjing Sike Pharmaceutical
- 01 Jul 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 22 May 2014 New trial record